Wisconsin - Session 2025REG
Title: prohibiting individuals under age 21 from accessing intoxicating hemp products and providing a penalty.
An Act to amend 94.55 (1); to create 94.55 (1m) and 94.56 of the statutes; Relating to: prohibiting individuals under age 21 from accessing intoxicating hemp products and providing a penalty. (FE)
Tracking state legislation? Support LegiList with a small contribution. Independent, ad-free, and built by one developer.
| Date | Event | Detail |
|---|---|---|
| 2025-11-14 | Introduced | Bill introduced |
| 2026-02-09 | Status | in_committee |
| 2026-02-09 | Latest Action | Representative J. Jacobson added as a cosponsor |
| Bill | Title | Status |
|---|---|---|
| AB 1112 | applying the indoor smoking ban to electronic delivery devices and marijuana. | in_committee |
| AB 1040 | maintaining a supply of usable opioid antagonist at a public or private school and making an appropriation. | in_committee |
| SB 1047 | modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. | in_committee |
| AB 747 | regulating hemp-derived cannabinoid products. | in_committee |
| SB 1083 | applying the indoor smoking ban to electronic delivery devices and marijuana. | in_committee |
| SB 534 | regulating medical cannabis, the prescription drug monitoring program, and providing a penalty. | in_committee |
| AB 1061 | legalizing the possession of cannabis; medical cannabis; expunging or adjusting past convictions for marijuana-related crimes; regulating the production, processing, transportation, testing, and sale of cannabis; granting rule-making authority; providing an exemption from emergency rule procedures; making an appropriation; and providing a penalty. | in_committee |
| AB 1081 | modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. | in_committee |